Evidence map›Paper›PMID 33193892›Full record

ArticleJournal of Cancer2020

Metachronous Brain Metastasis in patients with EGFR-mutant NSCLC indicates a worse prognosis.

Wen Ouyang, Jing Yu, Yan Zhou, Yu Xu, Jie Li, Jun Gong, Junhong Zhang, Conghua Xie

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Construction of a survival prediction model and analysis of influencing factors for brain metastasis in non-small cell lung cancer based on multi‑parameter clinical data.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  2. Survival of lung cancer patients with central nervous system metastases: from clinical trials to mouse models.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Wen OuyangDepartment of Radiation and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, China.
Jing YuDepartment of Radiation and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, China.
Yan ZhouDepartment of Radiation and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, China.
Yu XuDepartment of Radiation and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, China.
Jie LiDepartment of Radiation and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, China.
Jun GongDepartment of Radiation and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, China.
Junhong ZhangDepartment of Radiation and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, China.
Conghua XieDepartment of Radiation and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, China.
Zhongnan Hospital of Wuhan University · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

brain metastasesepidermal growth factor receptormetachronousnon-small cell lung cancersynchronous

Identifiers

PMID33193892
PMCPMC7646168
OpenAlexW3097553440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.